Navigation Links
Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M
Date:1/25/2012

,75289,810343,044307,386  Depreciation and amortization25,92325,919105,214103,024  Asset impairment charges---119,229Total costs and expenses543,434(a)

490,595(d)

2,055,817(c)

1,990,980(e)Income from operations38,951(a)

28,860(d)

180,629(c)

47,493(e)Other expense, net:  Interest expense, net3394301,97952  Foreign exchange transaction loss, net3561,0541,2483,649  Impairment of equity investment12,119-12,119-Other expense, net12,814(b)

1,48415,346(b)

3,701Income before taxes and equity investee earnings26,137(a),(b)

27,376(d)

165,283(b),(c)

43,792(e)Tax expense (benefit)5,172(a),(b)

(1,121)(d)

33,574(b),(c)

(23,655)(e)Equity investee earnings (loss)175(119)480807Net income$
21,140(a),(b)

$
28,378(d)

$
32,189(b),(c)

$
8,254(e)Basic earnings per share$
.35(a),(b)

$
.46(d)

$
2.22(b),(c)

$
.08(e)Weighted average shares outstanding - basic59,730,27061,390,96559,629,78863,043,561Diluted earnings per share$
.35(a),(b)

$
.45(d)

$
2.16(b),(c)

$
.06(e)Weighted average shares outstanding - diluted61,080,38762,703,69061,091,35464,472,326(a) Includes, as applicable, $8,667 in restructuring costs ($5,961 net of tax), $10,287 in costs associated with the termination of an inventory supply agreement and related inventory write-down ($7,130 net of tax) and favorable income tax items totaling $1,769 during the three months ended December, 2011.(b) Includes $12,119 impairment of equity investment ($12,119 net of tax) during the three and twelve months ended December 31, 2011.(c) Includes, as applicable, $24,369 in restructuring costs ($16,067 net of tax), $10,287 in costs associated with the termination of an inventory supply agreement and related inventory write-down ($7,130 net of tax) and favorable
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Covance Decides to Pursue Its Original Preclinical Strategy in China
2. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
3. Covance Purchases Equity Stake in Caprion Proteomics
4. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
5. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
6. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
7. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
8. Covance Elects John McCartney to Companys Board of Directors
9. Covance to Present at the Drug Information Associations 45th Annual Meeting
10. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
11. Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... DIEGO , Dec. 22, 2014 GenomeDx ... the Decipher Prostate Cancer Classifier, a genomic test for ... in node-negative, high-risk men managed by radical prostatectomy without ... radical prostatectomy is relatively uncommon, using tumor genomics to ... of metastatic disease is an important advance. The study ...
(Date:12/19/2014)... and Hershey, PA (PRWEB) December 19, 2014 ... BJCT), a leading developer and manufacturer of needle-free ... into an agreement with Immunomic Therapeutics, Inc. (“ITI”) ... needle-free injection device with its LAMP™ vaccine platform. ... option for an exclusive Worldwide license to the ...
(Date:12/19/2014)... CITY, Calif. , Dec. 19, 2014 Bina ... , USA) announced today that they have been acquired ... 1,2 is a privately held company that provides ... of next generation sequencing (NGS) data for the academic ... the Roche Sequencing Unit, and will continue to focus ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 LayerBio ... for ophthalmology and wound care. The National Eye Institute ... awarded LayerBio a Phase I SBIR grant to develop ... Cataracts are the most common cause of vision loss ... of blindness worldwide. According to Dr. Ken Mandell, LayerBio’s ...
Breaking Biology Technology:Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... Group Inc. (Nasdaq: GSIG ), a supplier of ... identified errors related to timing of the recognition of revenue ... during fiscal year 2006. The Audit Committee of the Board ... of potential adjustments resulting from the identified errors is material ...
... A Complimentary WebinarMOUNTAIN VIEW, Calif., March 30 , - TOPIC: ... current and potential impact on drug discovery, molecular, ... - WHEN: Tuesday, March 31, 2009, ... Online with free registration, - HOST: Christi ...
... provider of electronic informed consent software for clinical research trials ... Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical ... feasibility assessment, through clinical development to commercialization. , ... ...
Cached Biology Technology:GSI Group Inc. to Restate Financial Results for 2006 2Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics 2Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer 2
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/5/2014)... 2014  Tute Genomics, a leader in cloud-based solutions ... A1 funding led by UK-based Eurovestech. Peak Ventures and ... investment round. "We are at a pivotal ... sequencing and seeks new approaches for the diagnosis, treatment ... MD MBA, and CEO of Tute Genomics. "One of ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... new study suggests that preterm infants may not be ... United Kingdom immunization schedule. The findings are reported in ... Vaccine Immunology . The study, conducted by researchers ... neonatal intensive care units. The survey found that preterm ...
... This release is available in German . ... and reliable testing of HIV inhibitors. This system was developed ... of Virology. At the heart of the system are cultured ... and that signal HIV infection by producing a red fluorescent ...
... has cheated on you for the umpteenth time and their ... researchers at Binghamton University, they may be right. The propensity ... In a first of its kind study, a team of ... in the laboratory of evolutionary anthropology and health at Binghamton ...
Cached Biology News:A powerful new technology to identify HIV inhibitors 2New study suggests that a propensity for 1-night stands, uncommitted sex could be genetic 2New study suggests that a propensity for 1-night stands, uncommitted sex could be genetic 3
Red Standard is sodium salt of resorufin....
Human Jagged 2 Biotinylated Affinity Purified PAb...
RayBio L Series 507: RayBio Label-based Antibody Array I (2 membranes) Class: Antibody Array Products Product Group: Antibody Array...
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
Biology Products: